Press Releases PureTech Health plc

Equities

PRTC

GB00BY2Z0H74

Market Closed - London S.E. Other stock markets 11:35:20 2024-04-26 am EDT			5-day change	1st Jan Change
218 ^GBX	+2.59%		+5.57%	+12.26%

Apr. 25	Transcript : PureTech Health plc, 2023 Earnings Call, Apr 25, 2024
Apr. 25	PureTech touts "momentum" as grants shrivel but annual loss narrows	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PureTech Health : Proxy Form for 2024 AGM	Apr. 25	PU
PureTech Health : Notice of Meeting for 2024 AGM	Apr. 25	PU
PureTech Announces Annual Results for Year Ended December 31, 2023	Apr. 25	BU
PureTech Health plc - Notice of Results	Apr. 19	AQ
PureTech Health: Notice of Results	Apr. 18	BU
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 in Idiopathic Pulmonary Fibrosis	Apr. 17	AQ
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis	Apr. 16	BU
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers	Apr. 11	BU
Seaport Therapeutics Launches with $100 Million Oversubscribed Series a Financing Round to Advance Novel Neuropsychiatric Medicines	Apr. 10	AQ
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions	Apr. 09	BU
PureTech Proposes $100 Million Capital Return	Mar. 19	BU
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion	Mar. 18	BU
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia	Mar. 13	BU
PureTech Health : INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K - Form 6-K	Mar. 04	PU
ReNAgade Therapeutics Appoints Joe Bolen, Ph.D., Chief Science Innovation Officer	Feb. 28	AQ
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx for Pediatric ADHD Patients in Japan	Feb. 28	AQ
PureTech to Present at Two Upcoming Investor Conferences	Feb. 27	BU
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan	Feb. 27	BU
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	BU
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion	Dec. 22	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PureTech Health plc

Equities

PRTC

GB00BY2Z0H74

Press Releases

Filters